nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—ABCC1—Dactinomycin—ocular cancer	0.266	0.35	CbGbCtD
Irinotecan—ABCG2—Dactinomycin—ocular cancer	0.178	0.234	CbGbCtD
Irinotecan—ABCC2—Carboplatin—ocular cancer	0.132	0.174	CbGbCtD
Irinotecan—ABCG2—Carboplatin—ocular cancer	0.12	0.157	CbGbCtD
Irinotecan—ABCB1—Dactinomycin—ocular cancer	0.0642	0.0844	CbGbCtD
Irinotecan—CES2—E2F transcription factor network—TFDP1—ocular cancer	0.00284	0.0122	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—CDKN2C—ocular cancer	0.0026	0.0112	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—CCND3—ocular cancer	0.00257	0.0111	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—CRTC1—ocular cancer	0.0024	0.0103	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—E2F5—ocular cancer	0.00216	0.00928	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—ID2—ocular cancer	0.00214	0.00921	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—E2F4—ocular cancer	0.00212	0.0091	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—MYBL2—ocular cancer	0.00212	0.0091	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—E2F2—ocular cancer	0.00208	0.00892	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—RBL1—ocular cancer	0.00208	0.00892	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00204	0.00877	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.002	0.0086	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—RBL2—ocular cancer	0.00191	0.00819	CbGpPWpGaD
Irinotecan—ACHE—Monoamine Transport—RBL2—ocular cancer	0.00181	0.00779	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—RBBP4—ocular cancer	0.0018	0.00773	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—E2F3—ocular cancer	0.0018	0.00773	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—CDC25A—ocular cancer	0.00171	0.00736	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—TFDP1—ocular cancer	0.00167	0.00719	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—HDAC1—ocular cancer	0.00165	0.00709	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—CCND3—ocular cancer	0.00152	0.00652	CbGpPWpGaD
Irinotecan—Neutropenic sepsis—Dactinomycin—ocular cancer	0.00148	0.205	CcSEcCtD
Irinotecan—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA11—ocular cancer	0.00141	0.00608	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—E2F1—ocular cancer	0.00136	0.00583	CbGpPWpGaD
Irinotecan—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNAQ—ocular cancer	0.00131	0.00565	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—CDK2—ocular cancer	0.00117	0.00503	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—GNA11—ocular cancer	0.00107	0.00461	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—GNAQ—ocular cancer	0.000998	0.00429	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.000994	0.00427	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—HDAC1—ocular cancer	0.000972	0.00418	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—RB1—ocular cancer	0.000962	0.00413	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—HDAC1—ocular cancer	0.0009	0.00387	CbGpPWpGaD
Irinotecan—CES2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000888	0.00382	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00084	0.00361	CbGpPWpGaD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.000826	0.00355	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—E2F1—ocular cancer	0.0008	0.00344	CbGpPWpGaD
Irinotecan—Extravasation—Carboplatin—ocular cancer	0.000791	0.11	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000771	0.00331	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—CDKN1B—ocular cancer	0.000749	0.00322	CbGpPWpGaD
Irinotecan—UGT1A9—PPAR Alpha Pathway—CDK4—ocular cancer	0.000695	0.00299	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—CDKN1A—ocular cancer	0.000691	0.00297	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—CDK2—ocular cancer	0.00069	0.00296	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000665	0.00286	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—EP300—ocular cancer	0.000658	0.00283	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000629	0.0027	CbGpPWpGaD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.000616	0.00265	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—CDK4—ocular cancer	0.000604	0.00259	CbGpPWpGaD
Irinotecan—TOP1—Caspase Cascade in Apoptosis—AKT1—ocular cancer	0.000594	0.00255	CbGpPWpGaD
Irinotecan—CES2—E2F transcription factor network—MYC—ocular cancer	0.000573	0.00246	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—RB1—ocular cancer	0.000567	0.00244	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.000537	0.00231	CbGpPWpGaD
Irinotecan—CES1—Fluoropyrimidine Activity—TP53—ocular cancer	0.000523	0.00225	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000482	0.00207	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000473	0.00203	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000466	0.002	CbGpPWpGaD
Irinotecan—UGT1A9—PPAR Alpha Pathway—CCND1—ocular cancer	0.000449	0.00193	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.000447	0.00192	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—CDKN1B—ocular cancer	0.000441	0.0019	CbGpPWpGaD
Irinotecan—Febrile neutropenia—Dactinomycin—ocular cancer	0.000426	0.0591	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000426	0.00183	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—CDKN1A—ocular cancer	0.000407	0.00175	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000406	0.00174	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000393	0.00169	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—EP300—ocular cancer	0.000388	0.00167	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—CDK4—ocular cancer	0.00038	0.00163	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000374	0.00161	CbGpPWpGaD
Irinotecan—Hepatomegaly—Dactinomycin—ocular cancer	0.000362	0.0503	CcSEcCtD
Irinotecan—UGT1A9—PPAR Alpha Pathway—MYC—ocular cancer	0.00036	0.00155	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—EP300—ocular cancer	0.000359	0.00154	CbGpPWpGaD
Irinotecan—CES1—E2F transcription factor network—MYC—ocular cancer	0.000338	0.00145	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.000333	0.00143	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—RB1—ocular cancer	0.000331	0.00142	CbGpPWpGaD
Irinotecan—CES2—NRF2 pathway—TGFB1—ocular cancer	0.000328	0.00141	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000326	0.0014	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000325	0.0014	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.000298	0.00128	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.000298	0.00128	CbGpPWpGaD
Irinotecan—Extravasation—Dactinomycin—ocular cancer	0.000294	0.0408	CcSEcCtD
Irinotecan—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.000283	0.00122	CbGpPWpGaD
Irinotecan—Ulcer—Dactinomycin—ocular cancer	0.000271	0.0376	CcSEcCtD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000267	0.00115	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000262	0.00112	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000262	0.00112	CbGpPWpGaD
Irinotecan—TOP1—Circadian rythm related genes—TP53—ocular cancer	0.000257	0.0011	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—CCND1—ocular cancer	0.000246	0.00105	CbGpPWpGaD
Irinotecan—Infection—Carboplatin—ocular cancer	0.000245	0.034	CcSEcCtD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00024	0.00103	CbGpPWpGaD
Irinotecan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000227	0.000977	CbGpPWpGaD
Irinotecan—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000227	0.000977	CbGpPWpGaD
Irinotecan—ACHE—ATF-2 transcription factor network—EP300—ocular cancer	0.000226	0.000971	CbGpPWpGaD
Irinotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000226	0.00097	CbGpPWpGaD
Irinotecan—Sepsis—Dactinomycin—ocular cancer	0.000222	0.0309	CcSEcCtD
Irinotecan—ACHE—Metabolism of proteins—EIF1AX—ocular cancer	0.000214	0.000917	CbGpPWpGaD
Irinotecan—Pain—Carboplatin—ocular cancer	0.000211	0.0292	CcSEcCtD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00021	0.000902	CbGpPWpGaD
Irinotecan—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000207	0.000891	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000206	0.000885	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000199	0.000853	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PSPH—ocular cancer	0.000198	0.000853	CbGpPWpGaD
Irinotecan—Body temperature increased—Carboplatin—ocular cancer	0.000195	0.027	CcSEcCtD
Irinotecan—CES1—NRF2 pathway—TGFB1—ocular cancer	0.000193	0.000831	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—EIF1AX—ocular cancer	0.00019	0.000818	CbGpPWpGaD
Irinotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000184	0.00079	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000182	0.000783	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—RPL39—ocular cancer	0.000171	0.000733	CbGpPWpGaD
Irinotecan—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.000168	0.0233	CcSEcCtD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000166	0.000715	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000157	0.000675	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PSPH—ocular cancer	0.000156	0.000671	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—RPL39—ocular cancer	0.000152	0.000654	CbGpPWpGaD
Irinotecan—Neutropenia—Dactinomycin—ocular cancer	0.00015	0.0209	CcSEcCtD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000149	0.000638	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PSPH—ocular cancer	0.000148	0.000637	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PSPH—ocular cancer	0.000148	0.000637	CbGpPWpGaD
Irinotecan—Pneumonia—Dactinomycin—ocular cancer	0.000144	0.02	CcSEcCtD
Irinotecan—ABCC1—Metabolism—PSPH—ocular cancer	0.000143	0.000614	CbGpPWpGaD
Irinotecan—Stomatitis—Dactinomycin—ocular cancer	0.00014	0.0194	CcSEcCtD
Irinotecan—BCHE—Metabolism—PSPH—ocular cancer	0.000139	0.000599	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PSPH—ocular cancer	0.000136	0.000584	CbGpPWpGaD
Irinotecan—UGT1A9—PPARA activates gene expression—EP300—ocular cancer	0.00013	0.00056	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00013	0.000558	CbGpPWpGaD
Irinotecan—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000128	0.000548	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PSPH—ocular cancer	0.000126	0.00054	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PSPH—ocular cancer	0.000125	0.000536	CbGpPWpGaD
Irinotecan—Flushing—Dactinomycin—ocular cancer	0.000119	0.0166	CcSEcCtD
Irinotecan—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.000117	0.000502	CbGpPWpGaD
Irinotecan—Chills—Dactinomycin—ocular cancer	0.000116	0.016	CcSEcCtD
Irinotecan—Alopecia—Dactinomycin—ocular cancer	0.000114	0.0158	CcSEcCtD
Irinotecan—ABCC1—Disease—SAG—ocular cancer	0.000113	0.000486	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00011	0.000473	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.000109	0.000467	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000106	0.000456	CbGpPWpGaD
Irinotecan—Ill-defined disorder—Dactinomycin—ocular cancer	0.000104	0.0144	CcSEcCtD
Irinotecan—Anaemia—Dactinomycin—ocular cancer	0.000104	0.0144	CcSEcCtD
Irinotecan—Malaise—Dactinomycin—ocular cancer	0.000101	0.014	CcSEcCtD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000101	0.000432	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000101	0.000432	CbGpPWpGaD
Irinotecan—Leukopenia—Dactinomycin—ocular cancer	0.0001	0.0139	CcSEcCtD
Irinotecan—ABCC1—Disease—E2F5—ocular cancer	0.0001	0.00043	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	9.95e-05	0.000427	CbGpPWpGaD
Irinotecan—ABCC1—Disease—E2F4—ocular cancer	9.8e-05	0.000421	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RBL1—ocular cancer	9.61e-05	0.000413	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RPL39—ocular cancer	9.61e-05	0.000413	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	9.59e-05	0.000412	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—MDM2—ocular cancer	9.47e-05	0.000407	CbGpPWpGaD
Irinotecan—Discomfort—Dactinomycin—ocular cancer	9.43e-05	0.0131	CcSEcCtD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	9.28e-05	0.000399	CbGpPWpGaD
Irinotecan—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	9.23e-05	0.000396	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PSPH—ocular cancer	9.22e-05	0.000396	CbGpPWpGaD
Irinotecan—Oedema—Dactinomycin—ocular cancer	9.15e-05	0.0127	CcSEcCtD
Irinotecan—Infection—Dactinomycin—ocular cancer	9.09e-05	0.0126	CcSEcCtD
Irinotecan—UGT1A1—NRF2 pathway—TGFB1—ocular cancer	9.03e-05	0.000388	CbGpPWpGaD
Irinotecan—UGT1A9—NRF2 pathway—TGFB1—ocular cancer	9.03e-05	0.000388	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PSPH—ocular cancer	9.01e-05	0.000387	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	8.99e-05	0.000386	CbGpPWpGaD
Irinotecan—Thrombocytopenia—Dactinomycin—ocular cancer	8.96e-05	0.0124	CcSEcCtD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	8.83e-05	0.000379	CbGpPWpGaD
Irinotecan—ABCC2—NRF2 pathway—TGFB1—ocular cancer	8.81e-05	0.000379	CbGpPWpGaD
Irinotecan—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	8.79e-05	0.000377	CbGpPWpGaD
Irinotecan—Anorexia—Dactinomycin—ocular cancer	8.72e-05	0.0121	CcSEcCtD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	8.64e-05	0.000371	CbGpPWpGaD
Irinotecan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	8.58e-05	0.000369	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—MDM2—ocular cancer	8.13e-05	0.000349	CbGpPWpGaD
Irinotecan—Decreased appetite—Dactinomycin—ocular cancer	7.95e-05	0.011	CcSEcCtD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	7.93e-05	0.000341	CbGpPWpGaD
Irinotecan—Fatigue—Dactinomycin—ocular cancer	7.89e-05	0.0109	CcSEcCtD
Irinotecan—Pain—Dactinomycin—ocular cancer	7.82e-05	0.0109	CcSEcCtD
Irinotecan—ALB—Metabolism—PSPH—ocular cancer	7.76e-05	0.000333	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TFDP1—ocular cancer	7.75e-05	0.000333	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	7.7e-05	0.000331	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	7.68e-05	0.00033	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—TGFB1—ocular cancer	7.65e-05	0.000329	CbGpPWpGaD
Irinotecan—Feeling abnormal—Dactinomycin—ocular cancer	7.54e-05	0.0105	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dactinomycin—ocular cancer	7.48e-05	0.0104	CcSEcCtD
Irinotecan—ALB—Folate Metabolism—TP53—ocular cancer	7.35e-05	0.000316	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	7.29e-05	0.000313	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—MDM2—ocular cancer	7.26e-05	0.000312	CbGpPWpGaD
Irinotecan—Body temperature increased—Dactinomycin—ocular cancer	7.23e-05	0.01	CcSEcCtD
Irinotecan—Abdominal pain—Dactinomycin—ocular cancer	7.23e-05	0.01	CcSEcCtD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	6.84e-05	0.000294	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PSPH—ocular cancer	6.8e-05	0.000292	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—TGFB1—ocular cancer	6.77e-05	0.000291	CbGpPWpGaD
Irinotecan—Hypersensitivity—Dactinomycin—ocular cancer	6.74e-05	0.00935	CcSEcCtD
Irinotecan—Asthenia—Dactinomycin—ocular cancer	6.56e-05	0.00911	CcSEcCtD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	6.47e-05	0.000278	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	6.32e-05	0.000272	CbGpPWpGaD
Irinotecan—Diarrhoea—Dactinomycin—ocular cancer	6.26e-05	0.00868	CcSEcCtD
Irinotecan—SLC22A3—Metabolism—GNA11—ocular cancer	6.24e-05	0.000268	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAML2—ocular cancer	6.15e-05	0.000264	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—GNA11—ocular cancer	6.02e-05	0.000259	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—HRAS—ocular cancer	5.83e-05	0.00025	CbGpPWpGaD
Irinotecan—Vomiting—Dactinomycin—ocular cancer	5.82e-05	0.00807	CcSEcCtD
Irinotecan—SLC22A3—Metabolism—GNAQ—ocular cancer	5.81e-05	0.000249	CbGpPWpGaD
Irinotecan—Rash—Dactinomycin—ocular cancer	5.77e-05	0.008	CcSEcCtD
Irinotecan—ALB—Hemostasis—GNAQ—ocular cancer	5.6e-05	0.000241	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	5.44e-05	0.000234	CbGpPWpGaD
Irinotecan—Nausea—Dactinomycin—ocular cancer	5.43e-05	0.00754	CcSEcCtD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	5.34e-05	0.000229	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—HRAS—ocular cancer	5.2e-05	0.000223	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HDAC1—ocular cancer	5.05e-05	0.000217	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GNA11—ocular cancer	4.92e-05	0.000211	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	4.79e-05	0.000206	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GNA11—ocular cancer	4.66e-05	0.0002	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GNA11—ocular cancer	4.66e-05	0.0002	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GNAQ—ocular cancer	4.57e-05	0.000196	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HDAC1—ocular cancer	4.5e-05	0.000193	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GNA11—ocular cancer	4.5e-05	0.000193	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—HRAS—ocular cancer	4.46e-05	0.000192	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GNA11—ocular cancer	4.39e-05	0.000188	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	4.38e-05	0.000188	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GNAQ—ocular cancer	4.34e-05	0.000186	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GNAQ—ocular cancer	4.34e-05	0.000186	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GNA11—ocular cancer	4.27e-05	0.000184	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PSPH—ocular cancer	4.19e-05	0.00018	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GNAQ—ocular cancer	4.18e-05	0.00018	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	4.18e-05	0.000179	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GNAQ—ocular cancer	4.08e-05	0.000175	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	4.04e-05	0.000174	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN2B—ocular cancer	4.03e-05	0.000173	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—HRAS—ocular cancer	3.98e-05	0.000171	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GNAQ—ocular cancer	3.97e-05	0.000171	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GNA11—ocular cancer	3.96e-05	0.00017	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GNA11—ocular cancer	3.92e-05	0.000169	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	3.84e-05	0.000165	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.69e-05	0.000158	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GNAQ—ocular cancer	3.68e-05	0.000158	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GNAQ—ocular cancer	3.65e-05	0.000157	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—CDK2—ocular cancer	3.58e-05	0.000154	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.5e-05	0.00015	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	3.39e-05	0.000146	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.37e-05	0.000145	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	3.35e-05	0.000144	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	3.34e-05	0.000144	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.29e-05	0.000141	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.21e-05	0.000138	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GNA11—ocular cancer	2.9e-05	0.000125	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GNA11—ocular cancer	2.84e-05	0.000122	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	2.75e-05	0.000118	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GNAQ—ocular cancer	2.7e-05	0.000116	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GNAQ—ocular cancer	2.64e-05	0.000113	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GNA11—ocular cancer	2.44e-05	0.000105	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	2.36e-05	0.000101	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	2.32e-05	9.98e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GNAQ—ocular cancer	2.27e-05	9.75e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MDM2—ocular cancer	2.24e-05	9.61e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GNA11—ocular cancer	2.14e-05	9.19e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—EP300—ocular cancer	2.09e-05	8.96e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1B—ocular cancer	2.04e-05	8.78e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EP300—ocular cancer	2.01e-05	8.65e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GNAQ—ocular cancer	1.99e-05	8.55e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1A—ocular cancer	1.89e-05	8.1e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.83e-05	7.87e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EP300—ocular cancer	1.79e-05	7.71e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB1—ocular cancer	1.75e-05	7.52e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—EP300—ocular cancer	1.64e-05	7.06e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—ocular cancer	1.56e-05	6.72e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TGFB1—ocular cancer	1.56e-05	6.7e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—EP300—ocular cancer	1.56e-05	6.69e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—EP300—ocular cancer	1.56e-05	6.69e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—EP300—ocular cancer	1.5e-05	6.46e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—EP300—ocular cancer	1.47e-05	6.29e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—ocular cancer	1.44e-05	6.19e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—EP300—ocular cancer	1.43e-05	6.13e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—ocular cancer	1.38e-05	5.92e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—EP300—ocular cancer	1.32e-05	5.68e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNA11—ocular cancer	1.32e-05	5.66e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—EP300—ocular cancer	1.31e-05	5.63e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—ocular cancer	1.26e-05	5.42e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—ocular cancer	1.23e-05	5.28e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNAQ—ocular cancer	1.23e-05	5.27e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—ocular cancer	1.22e-05	5.22e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—ocular cancer	1.08e-05	4.66e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—ocular cancer	9.92e-06	4.26e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—EP300—ocular cancer	9.69e-06	4.16e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—EP300—ocular cancer	9.47e-06	4.07e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—ocular cancer	9.42e-06	4.05e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—ocular cancer	9.42e-06	4.05e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—ocular cancer	9.08e-06	3.9e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—ocular cancer	8.85e-06	3.8e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—ocular cancer	8.63e-06	3.71e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—EP300—ocular cancer	8.16e-06	3.51e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—ocular cancer	7.99e-06	3.43e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—ocular cancer	7.92e-06	3.4e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—EP300—ocular cancer	7.15e-06	3.07e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—ocular cancer	5.86e-06	2.52e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—ocular cancer	5.72e-06	2.46e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—ocular cancer	4.93e-06	2.12e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—EP300—ocular cancer	4.4e-06	1.89e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—ocular cancer	4.32e-06	1.86e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—ocular cancer	2.66e-06	1.14e-05	CbGpPWpGaD
